Replies to post #136 on Ore Holdings Inc. (fka ORXE)

[keitern]

I don't see how you can fault yourself, buying here. It's not like this company has many liabilities. The purchaser of the genomics division is assuming many liabilities like severance, lease, and other. Plus, GLGC has decided that repositioning is the best use of their database after all, so their money losing strategy is gone, liabilities are assumed by others, and their cash burn is small. I see it as market forces at work and .81 is a resulting absurdity. Just my opinion with shares at .913